Global Medical REIT (GMRE)
(Delayed Data from NYSE)
$6.50 USD
-0.25 (-3.70%)
Updated Aug 6, 2025 04:00 PM ET
After-Market: $6.48 -0.02 (-0.31%) 7:24 PM ET
3-Hold of 5 3
B Value C Growth C Momentum B VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
GMRE 6.50 -0.25(-3.70%)
Will GMRE be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for GMRE based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for GMRE
Global Medical REIT (GMRE) Q2 FFO Meet Estimates
Global Medical REIT (GMRE) Q1 FFO Meet Estimates
GMRE: What are Zacks experts saying now?
Zacks Private Portfolio Services
Ashford Hospitality Trust (AHT) Reports Q1 Loss, Lags Revenue Estimates
Alexander's (ALX) Q1 FFO Beat Estimates
CubeSmart (CUBE) Tops Q1 FFO and Revenue Estimates
Other News for GMRE
Global Medical REIT Inc. (GMRE) Q2 2025 Earnings Call Transcript
YieldBoost GMRE To 41% Using Options
2 High-Yield Preferreds For Non-Cyclical Retirement Income
Global Medical REIT (GMRE) Reaffirms FY25 AFFO Projections
Global Medical REIT (GMRE) Exceeds Revenue Expectations in Q2